ProstaLund Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Public

  • Employees
  • 9

Employees

  • Stock Symbol
  • PLUN

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.10
  • (As of Friday Closing)

ProstaLund General Information

Description

Prostalund AB is a medical technology company engaged in development of products and treatments in urology.

Contact Information

Website
www.prostalund.se
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Scheelevagen 19
  • 223 63 Lund
  • Sweden
+46
Primary Industry
Drug Discovery
Stock Exchange
STO
Vertical(s)
Life Sciences
Corporate Office
  • Scheelevagen 19
  • 223 63 Lund
  • Sweden
+46

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProstaLund Stock Performance

As of 13-Jun-2025, ProstaLund’s stock price is $0.10. Its current market cap is $376K with 3.62M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.10 $0.11 $0.09 - $2.25 $376K 3.62M 21.6K -$0.85

ProstaLund Financials Summary

As of 31-Mar-2025, ProstaLund has a trailing 12-month revenue of $1.31M.

In Thousands,
USD 		TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 2,018 1,378 10,530 20,566
Revenue 1,312 1,298 2,076 1,716
EBITDA (2,138) (2,105) (1,561) (1,052)
Net Income (2,151) (2,140) (1,601) (1,094)
Total Assets 5,616 5,586 6,560 4,893
Total Debt 83 85 133 166
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ProstaLund Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ProstaLund‘s full profile, request access.

Request a free trial

ProstaLund Patents

  • 31

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

ProstaLund Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220233830-A1 Kit and method intended for prostate surgery Active 28-Jan-2021
US-20230338705-A1 Kit and method intended for prostate surgery Pending 28-Jan-2021
US-20230073955-A1 Kit and method intended for prostate surgery Pending 28-Jan-2021
EP-4284481-A1 A kit and method intended for prostate surgery Pending 28-Jan-2021
US-20240091504-A1 Kit and method intended for prostate surgery Pending 28-Jan-2021 A61M25/065
To view ProstaLund’s complete patent history, request access »

ProstaLund Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProstaLund Acquisitions (1)

ProstaLund’s most recent deal was a Merger/Acquisition with Nordisk Medicin & Teknik for . The deal was made on 05-Sep-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nordisk Medicin & Teknik 05-Sep-2014 Merger/Acquisition Pharmaceuticals
To view ProstaLund’s complete acquisitions history, request access »

ProstaLund Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Nordisk Medicin & Teknik Boras, Sweden 2009

ProstaLund FAQs

  • When was ProstaLund founded?

    ProstaLund was founded in 1991.

  • Where is ProstaLund headquartered?

    ProstaLund is headquartered in Lund, Sweden.

  • What is the size of ProstaLund?

    ProstaLund has 9 total employees.

  • What industry is ProstaLund in?

    ProstaLund’s primary industry is Drug Discovery.

  • Is ProstaLund a private or public company?

    ProstaLund is a Public company.

  • What is ProstaLund’s stock symbol?

    The ticker symbol for ProstaLund is PLUN.

  • What is the current stock price of ProstaLund?

    As of 13-Jun-2025 the stock price of ProstaLund is $0.10.

  • What is the current market cap of ProstaLund?

    The current market capitalization of ProstaLund is $376K.

  • What is ProstaLund’s current revenue?

    The trailing twelve month revenue for ProstaLund is $1.31M.

  • What is ProstaLund’s annual earnings per share (EPS)?

    ProstaLund’s EPS for 12 months was -$0.85.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »